Transenterix Inc (NYSEAMERICAN:TRXC) reported that the firm has obtained FDA 510(k) approval for the Senhance™ Surgical Robotic System. Todd M. Pope, the CEO and President,
MannKind Corporation (NASDAQ:MNKD) reported that the U.S. Food & Drug Administration has approved a revision to the Afrezza prescribing information to constitute new clinical data
Aldeyra Therapeutics Inc (NASDAQ:ALDX) announced recently the positive results from its Phase 2a clinical trial of topical ocular (ADX-102) for treatment of patients with a
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares dropped 20% lower at the beginning of the week immediately after announcing that its hepatitis C partnership with Johnson &
Antares Pharma Inc (NASDAQ:ATRS) announced recently the positive Phase III trials that may support the approval of Xyosted , which was initially known as the
The stock of Argos Therapeutics Inc (NASDAQ:ARGS) closed at $0.20 losing 3.85% in yesterday’s trading session. This provider today made a report outlining that for
ImmunoGen, Inc. (NASDAQ:IMGN) announced recently that they are entering into a partnership and option agreement with Jazz Pharmaceuticals plc –Ordinary Shares (NASDAQ:JAZZ) to develop and
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced recently that the European Commission (EC) has approved FOTIVDA® (tivozanib) to be used for the treatment of adults who are
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported the dosing of the first subject into its clinical study of ZENITH-1. This study is assessing up to 3 dosage
Cara Therapeutics Inc (NASDAQ:CARA) reported the appointment of Mani Mohindru, Ph.D., as CFO and Chief Strategy Officer, from August 15, 2017. Derek Chalmers, the CEO
Celsion Corporation (NASDAQ:CLSN) has recently announced the latest translational data from the OVATION study of the Phase 1b dose clinical trials that combined GEN-1, Company’s
Novavax, Inc. (NASDAQ:NVAX) recently announced positive results from the ongoing phase 2 safety and immunogenicity clinical trials of the RSV F Vaccine in older adults.
OpenText (USA) (NASDAQ:OTEX) has announced its plans to purchase the Guidance Software, Inc. (NASDAQ:GUID), the company that makes the forensic software for close to $222
Pet translators might not be a fantasy ten years from now, according to futurologist William Higham. Amazon.com, Inc. (NASDAQ:AMZN) has already backed the claims reiterating
Latest sources have revealed the fact that Moleculin Biotech Inc. (NASDAQ:MBRX) has finally signed an agreement with MD Anderson Cancer Center. The follows their deal
Transenterix Inc (NYSEAMERICAN:TRXC) reported that the firm has obtained FDA 510(k) approval for the Senhance™ Surgical Robotic System. Todd M. Pope, the CEO and President,
MannKind Corporation (NASDAQ:MNKD) reported that the U.S. Food & Drug Administration has approved a revision to the Afrezza prescribing information to constitute new clinical data
Aldeyra Therapeutics Inc (NASDAQ:ALDX) announced recently the positive results from its Phase 2a clinical trial of topical ocular (ADX-102) for treatment of patients with a
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares dropped 20% lower at the beginning of the week immediately after announcing that its hepatitis C partnership with Johnson &
Antares Pharma Inc (NASDAQ:ATRS) announced recently the positive Phase III trials that may support the approval of Xyosted , which was initially known as the
The stock of Argos Therapeutics Inc (NASDAQ:ARGS) closed at $0.20 losing 3.85% in yesterday’s trading session. This provider today made a report outlining that for
ImmunoGen, Inc. (NASDAQ:IMGN) announced recently that they are entering into a partnership and option agreement with Jazz Pharmaceuticals plc –Ordinary Shares (NASDAQ:JAZZ) to develop and
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) announced recently that the European Commission (EC) has approved FOTIVDA® (tivozanib) to be used for the treatment of adults who are
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported the dosing of the first subject into its clinical study of ZENITH-1. This study is assessing up to 3 dosage
Cara Therapeutics Inc (NASDAQ:CARA) reported the appointment of Mani Mohindru, Ph.D., as CFO and Chief Strategy Officer, from August 15, 2017. Derek Chalmers, the CEO
Celsion Corporation (NASDAQ:CLSN) has recently announced the latest translational data from the OVATION study of the Phase 1b dose clinical trials that combined GEN-1, Company’s
Novavax, Inc. (NASDAQ:NVAX) recently announced positive results from the ongoing phase 2 safety and immunogenicity clinical trials of the RSV F Vaccine in older adults.
OpenText (USA) (NASDAQ:OTEX) has announced its plans to purchase the Guidance Software, Inc. (NASDAQ:GUID), the company that makes the forensic software for close to $222
Pet translators might not be a fantasy ten years from now, according to futurologist William Higham. Amazon.com, Inc. (NASDAQ:AMZN) has already backed the claims reiterating
Latest sources have revealed the fact that Moleculin Biotech Inc. (NASDAQ:MBRX) has finally signed an agreement with MD Anderson Cancer Center. The follows their deal
